American Capital Advisory, LLC Cytokinetics Inc Transaction History
American Capital Advisory, LLC
- $185 Billion
- Q1 2025
A detailed history of American Capital Advisory, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, American Capital Advisory, LLC holds 5 shares of CYTK stock, worth $214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5Holding current value
$214% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
402Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$629 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$510 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$461 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$264 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$122 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.03B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...